IL6 and neoplasm: Compared with previous studies, the current research confirmed the association between baseline IL-6 and advanced ESCC patient prognosis and revealed IL-6’s close relationship with tumor immune cell expression and the immunosuppressive molecule PD-L1 within the tumor microenvironment.